Dose-response in stereotactic irradiation of lung tumors

Radiother Oncol. 2005 Oct;77(1):83-7. doi: 10.1016/j.radonc.2005.09.003. Epub 2005 Oct 4.

Abstract

The dose-response for local tumor control after stereotactic radiotherapy of 92 pulmonary tumors (36 NSCLC and 56 metastases) was evaluated. Short course irradiation of 1-8 fractions with different fraction doses was used. After a median follow-up of 14 months (2-85 months) 11 local recurrences were observed with significant advantage for higher doses. When normalization to a biologically effective dose (BED) is used a dose of 94Gy at the isocenter and 50Gy at the PTV-margin are demonstrated to give 50% probability of tumor control (TCD50). Multivariate analysis revealed the dose at the PTV-margin as the only significant factor for local control.

Publication types

  • Clinical Trial

MeSH terms

  • Carcinoma, Non-Small-Cell Lung / radiotherapy*
  • Dose-Response Relationship, Radiation
  • Follow-Up Studies
  • Humans
  • Lung Neoplasms / radiotherapy*
  • Lung Neoplasms / secondary
  • Multivariate Analysis
  • Radiotherapy, Conformal / methods*
  • Treatment Outcome